BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Heightened attention from regulators on product and process qu
 ality is causing movement away from traditional mAb platforms to tailored
 \, modified processes for complex biologics\, creating a huge unmet need 
 for a platform for experts dedicated to purification alone.\n\nThe Advanc
 ed Purification for Complex Biologics Summit is the only standalone confe
 rence focused on purification for biologics and novel modalities bringing
  together purification\, CMC and MSAT professionals to collaborate and re
 move purification bottlenecks to meet market delivery timelines.\n\nThis 
 in-depth 3-day event will feature the latest breakthroughs and cutting-ed
 ge content in AI and digital learning tools to help you save time during 
 downstream processing and boost efficiency.\n\nThis is your unique opport
 unity to meet 60+ purification and downstream processing experts includin
 g Sanofi and Takeda\, Eli Lilly and Co\, AstraZeneca\, Regeneron and more
  as they talk you through machine learning\, predictive modelling\, and c
 onsumables advancements to empower your process optimization\, moving a s
 tep closer to 100% product purity.\n\nURLs:Tickets:&nbsp\;https://go.evvn
 t.com/1893273-2?pid=185Brochure:&nbsp\;https://go.evvnt.com/1893273-3?pid
 =185\n\nPrices:Drug Developer Pricing - Conference + 1 Workshop: USD 3648
 .00\,Drug Developer Pricing - Conference Only: USD 2999.00\,Academic Pric
 ing - Conference + 1 Workshop: USD 3148.00\,Academic Pricing - Conference
  Only: USD 2599.00\,Solution Provider Pricing - Conference + 1 Workshop: 
 USD 4548.00\,Solution Provider Pricing - Conference Only: USD 3799.00\n\n
 Speakers:&nbsp\;André Guillaume\, Process Lead Purification\, Facilities 
 of the Future\, Plasma Derived Therapies\, Takeda\, Brian Hall\, Head of 
 US Biologics Characterization\, Expression and Purification\, Sanofi\, Da
 niel Ragheb\, Senior Scientist - Manufacturing Sciences and Technology\, 
 AstraZeneca\, Frank Agbogbo\, Vice President - Process Development\, Forg
 e Biologics\, Hilary Williams\, MSAT Process Engineer\, Genentech\, James
  Reilly\, Associate Director\, Purification Development\, Regeneron\, Ji 
 Zheng\, Downstream Process Development\, Bristol Myers Squibb\, Kalie Mix
 \, Principal Scientist\, Lab Head\, Large Molecule Research\, Sanofi\, Mi
  Jin\, Senior Director\, Head of Downstream and Drug Product Development\
 , Spark Therapeutics\, Onur Kas\, Head Of Gene Therapy Vector Core\, UCB\
 , Paridhi Agrawal\, Engineering Advisor\, Eli Lilly and Co.\, Sudha Babu\
 , Director/CMC Regulatory Lead\, Spark Therapeutics\, Ujwal Patil\, Senio
 r Scientist\, AstraZeneca\, Virginia Brophy\, Principal Scientist\, Lab H
 ead\, Large Molecule Research\, Sanofi\, Xiaolong Lyu\, Director of Downs
 tream Process Development\, University of Pennsylvania\, Yanhuai (Richard
 ) Ding\, Former Head of Purification Process Development\, Gene Therapy\,
  (formerly) Biogen\, Yonatan Abune\, Senior Engineer - Process Developmen
 t and Analytics\, Myeloid Therapeutics\n\nTime:&nbsp\;1:00 pm to 4:00 pm\
 n
DTEND:20231130T160000
DTSTAMP:20260512T231935Z
DTSTART:20231128T130000
LOCATION:Sonesta Philadelphia Rittenhouse Square\, 1800\, Market Street\, 
 Philadelphia\, Pennsylvania\, 19103\,
SEQUENCE:0
SUMMARY:Heightened attention from regulators on product and process qualit
 y is causing movement away from traditional mAb platforms to tailored\, m
 odified p...
UID:62cedf00-8db5-4b57-97a8-5041274453df
END:VEVENT
END:VCALENDAR